Alaunos Therapeutics Stock Market Value
| TCRT Stock | USD 3.16 0.39 10.99% |
| Symbol | Alaunos |
Alaunos Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alaunos Therapeutics. If investors know Alaunos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alaunos Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.30) | Revenue Per Share | Quarterly Revenue Growth 1 | Return On Assets | Return On Equity |
The market value of Alaunos Therapeutics is measured differently than its book value, which is the value of Alaunos that is recorded on the company's balance sheet. Investors also form their own opinion of Alaunos Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Alaunos Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alaunos Therapeutics' market value can be influenced by many factors that don't directly affect Alaunos Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alaunos Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alaunos Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alaunos Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Alaunos Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Alaunos Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Alaunos Therapeutics.
| 08/25/2025 |
| 11/23/2025 |
If you would invest 0.00 in Alaunos Therapeutics on August 25, 2025 and sell it all today you would earn a total of 0.00 from holding Alaunos Therapeutics or generate 0.0% return on investment in Alaunos Therapeutics over 90 days. Alaunos Therapeutics is related to or competes with Cyclerion Therapeutics, Pasithea Therapeutics, Vyne Therapeutics, Quoin Pharmaceuticals, Addex Therapeutics, Polyrizon, and AIM ImmunoTech. Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-c... More
Alaunos Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Alaunos Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Alaunos Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.01 | |||
| Information Ratio | 0.1189 | |||
| Maximum Drawdown | 36.12 | |||
| Value At Risk | (10.06) | |||
| Potential Upside | 12.1 |
Alaunos Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Alaunos Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Alaunos Therapeutics' standard deviation. In reality, there are many statistical measures that can use Alaunos Therapeutics historical prices to predict the future Alaunos Therapeutics' volatility.| Risk Adjusted Performance | 0.0971 | |||
| Jensen Alpha | 0.9549 | |||
| Total Risk Alpha | 0.4551 | |||
| Sortino Ratio | 0.1364 | |||
| Treynor Ratio | (0.37) |
Alaunos Therapeutics Backtested Returns
Alaunos Therapeutics appears to be dangerous, given 3 months investment horizon. Alaunos Therapeutics secures Sharpe Ratio (or Efficiency) of 0.14, which signifies that the company had a 0.14 % return per unit of standard deviation over the last 3 months. By analyzing Alaunos Therapeutics' technical indicators, you can evaluate if the expected return of 0.96% is justified by implied risk. Please makes use of Alaunos Therapeutics' mean deviation of 5.18, and Risk Adjusted Performance of 0.0971 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Alaunos Therapeutics holds a performance score of 11. The firm shows a Beta (market volatility) of -2.32, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Alaunos Therapeutics are expected to decrease by larger amounts. On the other hand, during market turmoil, Alaunos Therapeutics is expected to outperform it. Please check Alaunos Therapeutics' downside variance, and the relationship between the total risk alpha and daily balance of power , to make a quick decision on whether Alaunos Therapeutics' price patterns will revert.
Auto-correlation | -0.19 |
Insignificant reverse predictability
Alaunos Therapeutics has insignificant reverse predictability. Overlapping area represents the amount of predictability between Alaunos Therapeutics time series from 25th of August 2025 to 9th of October 2025 and 9th of October 2025 to 23rd of November 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Alaunos Therapeutics price movement. The serial correlation of -0.19 indicates that over 19.0% of current Alaunos Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.19 | |
| Spearman Rank Test | 0.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.13 |
Alaunos Therapeutics lagged returns against current returns
Autocorrelation, which is Alaunos Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Alaunos Therapeutics' stock expected returns. We can calculate the autocorrelation of Alaunos Therapeutics returns to help us make a trade decision. For example, suppose you find that Alaunos Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Alaunos Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Alaunos Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Alaunos Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Alaunos Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Alaunos Therapeutics Lagged Returns
When evaluating Alaunos Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Alaunos Therapeutics stock have on its future price. Alaunos Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Alaunos Therapeutics autocorrelation shows the relationship between Alaunos Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Alaunos Therapeutics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Alaunos Stock Analysis
When running Alaunos Therapeutics' price analysis, check to measure Alaunos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alaunos Therapeutics is operating at the current time. Most of Alaunos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Alaunos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alaunos Therapeutics' price. Additionally, you may evaluate how the addition of Alaunos Therapeutics to your portfolios can decrease your overall portfolio volatility.